III. Small Cerebral Hemorrhage in Cerebral Hemorrhage

As a special case, it is important to recognize and treat it differently. The cerebellum is located on the lateral side of the brainstem and medulla oblongata, bordering the brainstem at its base. It accounts for 1/10 of the brain’s total weight, and its blood supply comes from branches of the vertebral-basilar artery. Therefore, arteriosclerosis of the vertebral-basilar artery is the primary cause of cerebellar hemorrhage. The cerebellum’s function is to maintain bodily balance and coordination; when hemorrhage or infarction occurs, patients may experience imbalance in coordination, with symptoms such as dizziness, instability when standing, tinnitus, headache, and vomiting. The cerebellum is adjacent to the fourth ventricle; when hemorrhage occurs in the cerebellum, it can often spill into the fourth ventricle, affecting the smooth flow of the cerebral aqueduct and causing increased intracranial pressure, which in turn triggers meningeal irritation symptoms, leading to severe headaches and projectile vomiting. Some patients may also experience language impairment, nystagmus, persistent wheezing, decreased muscle tone, and dullness in sensation throughout the body—symptoms reminiscent of brainstem issues. Treatment for this condition should include formulas such as Blood Palace Dispersing Stasis Decoction, Er Xian Tang, Chuanxiong Tiao Cha San, Xuan Fu Dai He Tang, Wu Ling San, and Half-Hook Compound—some of these formulas may be classic formulas or well-known formulas, all of which have historical roots. However, the Half-Hook Compound is a formula based on my clinical experience: half-buried ginger, Uncaria, Plantago Seed, Xia Ku Cao, raw Hematite, Houpu, Poria, Alisma, White Atractylodes—boiled in water and taken as one dose per day. Originally, I intended this formula for ear-related dizziness, but later, when patients with arterial sclerosis began to experience problems with cerebellar blood supply—whether due to infarction or hemorrhage—their primary symptom was dizziness. Thus, I started using this formula to treat cases where arteriosclerosis of the vertebral-basilar artery led to hemorrhage or infarction, and the formula proved effective. In conclusion, among the many formulas mentioned above, choose the appropriate one based on the condition and flexibly adjust the formulation. Sometimes, it is still necessary to add stronger blood-dispersing herbs such as leeches and Sanqi from the Han Dynasty.

Hypertension is the underlying cause of cerebral hemorrhage, and arterial sclerosis always plays a role in the process. From Yin Deficiency and Yang Excess to Yang Excess leading to Wind, this is also the pathological process of hypertension-related arterial sclerosis in Western medicine. TCM says, “To treat wind, first activate blood circulation; when blood is active, wind naturally dissipates,” which truly captures the essence of this condition. From Blood Palace Dispersing Stasis Decoction and Bu Yang Huan Wu Decoction to Coronary Heart Disease No. 2, Compound Dan Shen Tablets, Dan Shen Drops, and Tong Mai Ling, the core principle remains the same: activating blood circulation to remove stasis. My experience shows that most patients with hypertension can be treated with traditional Chinese medicine alone—taking herbal decoctions first to alleviate symptoms and lower blood pressure, followed by long-term use of pills and powders, which not only prevents blood pressure from rebounding but also plays a crucial role in slowing down and preventing complications such as arterial sclerosis in the heart, brain, and kidneys; at the same time, it can also have a positive impact on controlling blood lipids, blood viscosity, and uric acid levels.

Another advantage of traditional Chinese medicine in treating cerebral hemorrhage lies in its ability to address sequelae. The aforementioned formulas—Bu Yang Huan Wu, Blood Palace Dispersing Stasis, Zhen Gan Xi Feng, Dihuang Yin Zi, Er Xian Tang—can also be used to treat sequelae. My experience shows that for patients with heavy bleeding, who are unconscious, snoring, experiencing pupil changes, or experiencing a sharp increase in intracranial pressure, emergency treatment with Western medicine is necessary. In cases where immediate craniotomy and tube insertion for decompression are required, do not miss the opportunity to save the patient; for patients with minor or moderate bleeding during the acute phase, Western medical measures should still be implemented, while combining them with traditional Chinese medicine can yield even better results. Once the bleeding has stopped, patients who still suffer from hemiplegia, speech disorders, or facial deviation may require traditional Chinese medicine treatment—current Western medical treatments such as anticoagulation, thrombolysis, and laser therapy are not ideal for such cases. Although traditional Chinese medicine works slowly, consistent medication can lead to varying degrees of improvement in most patients.

Whether it’s hypertension or sequelae after cerebral hemorrhage, given that long-term use of traditional Chinese medicine can sometimes damage the stomach’s qi, it is essential to add a small amount of gastric protective medications to the formula, such as Sand Ren, Wood Odor, or Grass Cardamom.

Conversations on Liver Disease Treatment

Liver diseases include hepatitis, cirrhosis, hepatic echinococcosis, liver mass lesions, and secondary liver diseases. In recent years, with the spread of hepatitis B, people have become increasingly aware of hepatitis B and the resulting cirrhosis and liver Task output rules: Translate this markdown block from Chinese to English. Preserve markdown markers, links, and formatting. Keep headings and list structure unchanged. Return only the translated block.

Input: Cancer is highly valued, and countries around the world have invested substantial human, material, and financial resources in research on it. Reports on hepatitis and related diseases are emerging like mushrooms after a spring rain, overwhelming researchers. Due to the high incidence of these diseases, hepatitis B alone has affected more than 100 million people domestically. In addition to hepatitis B, there are also infectious liver diseases such as hepatitis A, hepatitis C, hepatitis D, hepatitis E, and hepatitis G. Given that all infectious liver diseases can lead to cirrhosis and liver cancer, the incidence of these diseases in China has been on the rise in recent years. Hepatic echinococcosis is found only in a small number of provinces in northwestern China. Secondary liver diseases, such as lupus hepatitis, cardiogenic liver disease, hematogenous liver disease, and immune-related liver disease, are often complications of other illnesses and occur sporadically, with no significant differences in incidence across different regions.

This article will discuss my own experiences and insights regarding the incidence, clinical manifestations, and treatment options for hepatitis B, cirrhosis, and liver cancer. I will share my thoughts freely, taking full responsibility for the content.

In 1963, American scholars Bloomberg and others discovered the "Australian antigen." In 1968, Japanese scholars Okoe-Ki and others confirmed the relationship between this antigen and liver disease. Subsequent experimental studies by numerous researchers repeatedly demonstrated that the Australian antigen is a key factor in causing liver disease. The liver disease triggered by the Australian antigen was officially named hepatitis B at the International Liver Disease Conference in 1970. The Australian antigen was then designated as "hepatitis B-associated antigen" (HAA). At that time, hepatitis B was widespread globally, particularly in Asian regions such as Indonesia, the Philippines, Taiwan, Hong Kong, mainland China, Vietnam, Myanmar, where the incidence rapidly increased. In some areas, the prevalence of hepatitis B had reached as high as about 20% of the population. During that period, China was experiencing the peak of the Cultural Revolution, during which scientific research stagnated and publications were discontinued, and hepatitis B was rampant throughout the country without restraint. The Shanghai Institute of Infectious Diseases had already reported clinical studies on hepatitis B before the Cultural Revolution, but these efforts were forced to halt during the revolution, and observations and research on hepatitis B across the country were also brought to a standstill at their early stages.

After the Cultural Revolution, starting in the 1970s, research on hepatitis B in China quickly resumed. Comprehensive surveys and analyses conducted across various regions revealed that the prevalence of hepatitis B in China ranged from 8% to 15%. This figure was large enough to attract widespread public attention. Beginning in 1984, I took the lead in establishing the "Clinical Research Group on Hepatitis B" at the Gansu Provincial Institute of New Medicine, where we undertook a key national research project focused on hepatitis B during the Seventh Five-Year Plan period. After nearly 10 years of clinical observation and experimentation, we observed the following through over 60,000 cases of hepatitis B: